Recent Posts
- New Evidence Supports the Value of Elutia’s Antibiotic-Eluting Platform for Implantable Devices
- Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards
- Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method
- Elutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluPro™ Sales
- Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio